Vicora

Buffalo, United States

Vicora offers treatment of numerous vascular illnesses, including pulmonary embolism, deep vein thrombosis.

$3.4M raised

May 2025

Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Vicora raised?

Vicora has raised $3.4M in total funding. The most recent round was Seed. The last funding was announced in May 2025.

Who are Vicora's investors?

Vicora's investors include S2 Ventures Partners, Egret Healthcare Ventures.

Where is Vicora headquartered?

Vicora is headquartered in Buffalo, United States.

What does Vicora do?

Vicora offers treatment of numerous vascular illnesses, including pulmonary embolism, deep vein thrombosis.

What stage is Vicora at?

Vicora is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 9, 2025.

MLA

"Vicora — Funding & Investors." VCBacked, May 9, 2025, https://www.vcbacked.co/company/vicora. Accessed July 2, 2026.

APA

VCBacked. (2025). Vicora — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/vicora

Wikipedia (cite web)

{{cite web |title=Vicora — Funding & Investors |url=https://www.vcbacked.co/company/vicora |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 9, 2025.